Diffusion-weighted breast MRI in prediction of upstaging in women with biopsy-proven ductal carcinoma in situ

SA Lee, Y Lee, HS Ryu, M Jang, WK Moon, HG Moon… - Radiology, 2022 - pubs.rsna.org
Background Accurate preoperative prediction of upstaging in women with biopsy-proven
ductal carcinoma in situ (DCIS) is important for surgical planning, but published models …

Prediction of occult invasive disease in ductal carcinoma in situ using deep learning features

B Shi, LJ Grimm, MA Mazurowski, JA Baker… - Journal of the American …, 2018 - Elsevier
Purpose The aim of this study was to determine whether deep features extracted from digital
mammograms using a pretrained deep convolutional neural network are prognostic of occult …

Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI‐Based Radiomics

M Hong, S Fan, Z Yu, C Gao, Z Fang… - Journal of Magnetic …, 2023 - Wiley Online Library
Background About 20%–40% of patients diagnosed with ductal carcinoma in situ (DCIS) by
core needle biopsy (CNB) will develop invasive cancer at the time of excision. Improving the …

Ductal carcinoma in situ: treatment or active surveillance?

HM Kuerer - Expert review of anticancer therapy, 2015 - Taylor & Francis
Ductal carcinoma-in situ (DCIS) is a non-obligate precursor for invasive breast cancer and
concern exists regarding the potential for overdiagnosis and overtreatment as the natural …

A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease

JW Jakub, BL Murphy, AB Gonzalez… - Annals of surgical …, 2017 - Springer
Abstract Background Approximately 8–56% of patients with a core needle biopsy (CNB)
diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive disease at the time …

Development of a model to predict invasiveness in ductal carcinoma in situ diagnosed by percutaneous biopsy—original study and critical evaluation of the literature

MT Dória, JY Maesaka, RS de Azevedo Neto… - Clinical breast …, 2018 - Elsevier
Background Approximately 30% of ductal carcinoma in situ (DCIS) cases have an invasive
component discovered on the final analysis that could affect surgical management. The aims …

Prognostic nomogram for prediction of axillary pathologic complete response after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer

JY Kim, HS Park, S Kim, J Ryu, S Park, SI Kim - Medicine, 2015 - journals.lww.com
Prognostic Nomogram for Prediction of Axillary Pathologic Co... : Medicine Prognostic
Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant …

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive …

CJC Meurs, J van Rosmalen… - British journal of …, 2018 - nature.com
Background Patients with a biopsy diagnosis of ductal carcinoma in situ (DCIS) might be
diagnosed with invasive breast cancer at excision, a phenomenon known as …

Nomogram for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using dynamic contrast-enhanced and diffusion …

R Zhao, H Lu, YB Li, ZZ Shao, WJ Ma, PF Liu - Academic Radiology, 2022 - Elsevier
Rationale and Objectives: The study investigated the potential of the combined use of
dynamic contrast-enhanced MRI and diffusion-weighted imaging in predicting the …

Validation and clinical utility of a prediction model for the risk of upstaging to invasive breast cancer after a biopsy diagnosis ductal carcinoma in situ

CJC Meurs, S van Bekkum, J van Rosmalen… - Annals of surgical …, 2023 - Springer
Background This study aimed to validate the DCIS-upstage model, a previously developed
model to predict the risk of upstaging to invasive breast cancer in patients with biopsy …